Logo image of ATRC

ATRICURE INC (ATRC) Stock Overview

USA - NASDAQ:ATRC - US04963C2098 - Common Stock

35.96 USD
+1.33 (+3.84%)
Last: 9/16/2025, 8:00:01 PM
35.96 USD
0 (0%)
After Hours: 9/16/2025, 8:00:01 PM

ATRC Key Statistics, Chart & Performance

Key Statistics
52 Week High43.11
52 Week Low25.57
Market Cap1.79B
Shares49.70M
Float47.96M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.41
PEN/A
Fwd PEN/A
Earnings (Next)10-27 2025-10-27/amc
IPO08-05 2005-08-05
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


ATRC short term performance overview.The bars show the price performance of ATRC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10

ATRC long term performance overview.The bars show the price performance of ATRC in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10 20

The current stock price of ATRC is 35.96 USD. In the past month the price increased by 0.95%. In the past year, price increased by 23.91%.

ATRICURE INC / ATRC Daily stock chart

ATRC Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.09 231.06B
ISRG INTUITIVE SURGICAL INC 53.98 155.76B
BSX BOSTON SCIENTIFIC CORP 34.98 146.66B
SYK STRYKER CORP 29.31 143.99B
MDT MEDTRONIC PLC 17.03 120.82B
BDX BECTON DICKINSON AND CO 13.05 53.37B
IDXX IDEXX LABORATORIES INC 53.76 51.65B
EW EDWARDS LIFESCIENCES CORP 29.22 44.09B
RMD RESMED INC 28.54 39.91B
GEHC GE HEALTHCARE TECHNOLOGY 16.63 35.37B
DXCM DEXCOM INC 45.03 30.02B
PHG KONINKLIJKE PHILIPS NVR- NY 16.6 27.02B

About ATRC

Company Profile

ATRC logo image AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. The company is headquartered in Mason, Ohio and currently employs 1,300 full-time employees. The company went IPO on 2005-08-05. The firm's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The firm's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

Company Info

ATRICURE INC

7555 Innovation Way

Mason OHIO 45040 US

CEO: Michael H. Carrel

Employees: 1300

ATRC Company Website

ATRC Investor Relations

Phone: 15137554100

ATRICURE INC / ATRC FAQ

What is the stock price of ATRICURE INC today?

The current stock price of ATRC is 35.96 USD. The price increased by 3.84% in the last trading session.


What is the ticker symbol for ATRICURE INC stock?

The exchange symbol of ATRICURE INC is ATRC and it is listed on the Nasdaq exchange.


On which exchange is ATRC stock listed?

ATRC stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ATRICURE INC stock?

15 analysts have analysed ATRC and the average price target is 52.02 USD. This implies a price increase of 44.66% is expected in the next year compared to the current price of 35.96. Check the ATRICURE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ATRICURE INC worth?

ATRICURE INC (ATRC) has a market capitalization of 1.79B USD. This makes ATRC a Small Cap stock.


How many employees does ATRICURE INC have?

ATRICURE INC (ATRC) currently has 1300 employees.


What are the support and resistance levels for ATRICURE INC (ATRC) stock?

ATRICURE INC (ATRC) has a support level at 35.06 and a resistance level at 37.18. Check the full technical report for a detailed analysis of ATRC support and resistance levels.


Is ATRICURE INC (ATRC) expected to grow?

The Revenue of ATRICURE INC (ATRC) is expected to grow by 14.51% in the next year. Check the estimates tab for more information on the ATRC EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ATRICURE INC (ATRC) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ATRICURE INC (ATRC) stock pay dividends?

ATRC does not pay a dividend.


When does ATRICURE INC (ATRC) report earnings?

ATRICURE INC (ATRC) will report earnings on 2025-10-27, after the market close.


What is the Price/Earnings (PE) ratio of ATRICURE INC (ATRC)?

ATRICURE INC (ATRC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.41).


What is the Short Interest ratio of ATRICURE INC (ATRC) stock?

The outstanding short interest for ATRICURE INC (ATRC) is 4.34% of its float. Check the ownership tab for more information on the ATRC short interest.


ATRC Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to ATRC. When comparing the yearly performance of all stocks, ATRC is one of the better performing stocks in the market, outperforming 78.25% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ATRC Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to ATRC. ATRC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ATRC Financial Highlights

Over the last trailing twelve months ATRC reported a non-GAAP Earnings per Share(EPS) of -0.41. The EPS increased by 52.33% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -5.97%
ROE -7.83%
Debt/Equity 0.15
Chartmill High Growth Momentum
EPS Q2Q%88.24%
Sales Q2Q%17.09%
EPS 1Y (TTM)52.33%
Revenue 1Y (TTM)16.28%

ATRC Forecast & Estimates

15 analysts have analysed ATRC and the average price target is 52.02 USD. This implies a price increase of 44.66% is expected in the next year compared to the current price of 35.96.

For the next year, analysts expect an EPS growth of 35.7% and a revenue growth 14.51% for ATRC


Analysts
Analysts85.33
Price Target52.02 (44.66%)
EPS Next Y35.7%
Revenue Next Year14.51%

ATRC Ownership

Ownership
Inst Owners104.63%
Ins Owners3.46%
Short Float %4.34%
Short Ratio3.87